Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-038885)

Filing Details

Accession Number:: 0001209191-23-038885
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-21 18:17:06
Reporting Period:: 2023-06-19

Accepted Time:: 2023-06-21 18:17:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1515673	Ultragenyx Pharmaceutical Inc.	RARE	Pharmaceutical Preparations (2834)	272546083

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780113	Erik Harris	60 Leveroni Court Novato CA 94949	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-19	305	$48.20	57,281	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
Includes 242 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.